Epidemiology of interdialytic ambulatory hypertension and the role of volume excess

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP). Methods: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated. Results: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs. Conclusions: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.

Original languageEnglish
Pages (from-to)381-390
Number of pages10
JournalAmerican Journal of Nephrology
Volume34
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Epidemiology
Hypertension
Antihypertensive Agents
Blood Pressure
Renal Dialysis
Inferior Vena Cava
Cross-Sectional Studies
Ambulatory Blood Pressure Monitoring
Extracellular Fluid
Dialysis
Body Mass Index

Keywords

  • Ambulatory blood pressure monitoring
  • Epidemiology
  • Epoetin
  • Hemodialysis
  • Hypertension
  • Vitamin D receptor activators

ASJC Scopus subject areas

  • Nephrology

Cite this

Epidemiology of interdialytic ambulatory hypertension and the role of volume excess. / Agarwal, Rajiv.

In: American Journal of Nephrology, Vol. 34, No. 4, 10.2011, p. 381-390.

Research output: Contribution to journalArticle

@article{cd8d904943d7444397ff927552973b3c,
title = "Epidemiology of interdialytic ambulatory hypertension and the role of volume excess",
abstract = "Background: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP). Methods: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated. Results: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82{\%} of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89{\%} of the patients were being treated, hypertension was controlled adequately in only 38{\%}. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs. Conclusions: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.",
keywords = "Ambulatory blood pressure monitoring, Epidemiology, Epoetin, Hemodialysis, Hypertension, Vitamin D receptor activators",
author = "Rajiv Agarwal",
year = "2011",
month = "10",
doi = "10.1159/000331067",
language = "English",
volume = "34",
pages = "381--390",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Epidemiology of interdialytic ambulatory hypertension and the role of volume excess

AU - Agarwal, Rajiv

PY - 2011/10

Y1 - 2011/10

N2 - Background: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP). Methods: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated. Results: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs. Conclusions: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.

AB - Background: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP). Methods: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated. Results: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs. Conclusions: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.

KW - Ambulatory blood pressure monitoring

KW - Epidemiology

KW - Epoetin

KW - Hemodialysis

KW - Hypertension

KW - Vitamin D receptor activators

UR - http://www.scopus.com/inward/record.url?scp=80052309549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052309549&partnerID=8YFLogxK

U2 - 10.1159/000331067

DO - 10.1159/000331067

M3 - Article

C2 - 21893975

AN - SCOPUS:80052309549

VL - 34

SP - 381

EP - 390

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 4

ER -